These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5069316)

  • 41. On the mechanism of action of galactosamine: different response to D-galactosamine of rat liver during development.
    Reutter W; Bauer C; Lesch R
    Naturwissenschaften; 1970 Dec; 57(12):674-5. PubMed ID: 5531365
    [No Abstract]   [Full Text] [Related]  

  • 42. Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat.
    Grün M; Liehr H; Rasenack U
    Acta Hepatogastroenterol (Stuttg); 1977 Apr; 24(2):64-81. PubMed ID: 857560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzymatic defence against oxygen toxicity in D-galactosamine-induced hepatitis in rats.
    D'Souza NB; Kulkarni AB; Baxi AJ; Nadkarni GD
    Indian J Gastroenterol; 1985 Apr; 4(2):87-8. PubMed ID: 3845914
    [No Abstract]   [Full Text] [Related]  

  • 44. [The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
    Schriewer H; Rausen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:159. PubMed ID: 4740687
    [No Abstract]   [Full Text] [Related]  

  • 45. Induction of tyrosine aminotransferase in galactosamine hepatitis.
    Pugge HR; Torrecilla A; Pellanda RJ
    Acta Gastroenterol Latinoam; 1979; 9(3):159-63. PubMed ID: 43646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [AFP producing cells during liver restitution after acute galactosamine hepatitis in the rat (author's transl)].
    Noguchi T
    Nihon Shokakibyo Gakkai Zasshi; 1978 Dec; 75(12):1972-82. PubMed ID: 84084
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparison between the morphologic changes in the livers of hamsters and rats after galactosamine treatment and their correlation with altered serum transaminase levels.
    Pickering RW
    Arzneimittelforschung; 1977; 27(9):1684-7. PubMed ID: 579138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preliminary observations on D-galactosamine-induced hepatic failure in rat models (author's transl)].
    Niu Z
    Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):350-3. PubMed ID: 6796235
    [No Abstract]   [Full Text] [Related]  

  • 49. [Mechanism of action of D-galactosamine in the liver].
    Keppler D; Decker K
    Verh Dtsch Ges Inn Med; 1971; 77():1182-5. PubMed ID: 5155985
    [No Abstract]   [Full Text] [Related]  

  • 50. [Morphological characteristics of D-galactosamine hepatitis].
    Popov A; Klouchek-Popova E; Stoilova M
    Eksp Med Morfol; 1983; 22(2):74-80. PubMed ID: 6667658
    [No Abstract]   [Full Text] [Related]  

  • 51. Rat alpha 1-fetoprotein: appearance after galactosamine-induced liver injury.
    Sell S; Reynolds RD; Reutter W
    J Natl Cancer Inst; 1974 Jul; 53(1):289-91. PubMed ID: 4835112
    [No Abstract]   [Full Text] [Related]  

  • 52. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.
    Decker K; Keppler D
    Rev Physiol Biochem Pharmacol; 1974; (71):77-106. PubMed ID: 4375846
    [No Abstract]   [Full Text] [Related]  

  • 53. Aggravating and protecting effects of triton and corticosteroids in galactosamine-induced hepatitis.
    Grases PJ; Lesch R; Stein U; Heissmeyer H; Reutter W
    G E N; 1972; 27(1):77-89. PubMed ID: 4632028
    [No Abstract]   [Full Text] [Related]  

  • 54. [Long-term cross-circulation on galactosamine induced hepatic failure rats].
    Okabe K; Koyama K; Ouchi K; Asanuma Y; Sato T
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):445-51. PubMed ID: 6749112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of calcium in liver cell damage. Comparative studies with carbon tetrachloride and D-galactosamine.
    Kröner H; Planker M
    Pathol Res Pract; 1980 Nov; 169(3-4):298-303. PubMed ID: 6261229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galactosamine- "hepatitis" in rats with different phagocytic activity of liver RES.
    Rasenack U; Grün M; Liehr H
    Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):29-35. PubMed ID: 1119301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Undesirable metabolic effects following the administration of larger doses of fructose and sorbitol].
    Bode JC
    Infusionstherapie (1973); 1974 Oct; 1(7):558-63. PubMed ID: 4219394
    [No Abstract]   [Full Text] [Related]  

  • 58. [Behavior of 125-I-fibrinogen and 131-I-albumin in experimental galactosamine hepatitis].
    von Mahn I; Merkel H; Sattler EL; Müller-Berghaus G
    Verh Dtsch Ges Inn Med; 1974; 80():437-9. PubMed ID: 4454578
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.
    Sommer BG; Sutherland DE; Matas AJ; Simmons RL; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):578-84. PubMed ID: 377697
    [No Abstract]   [Full Text] [Related]  

  • 60. An investigation and some parameters that affect the galactosamine model of hepatitis in the rat.
    Pickering RW; James GW; Parker FL
    Arzneimittelforschung; 1975 Jun; 25(6):898-901. PubMed ID: 1174326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.